Science
Mechanism of Action
This synthetic recombinant human CTGF analog peptide specifically targets the Insulin-like Growth Factor (IGF)-binding domain of CTGF. By doing so, it precisely regulates the genetic expression pathways in fibroblasts responsible for collagen synthesis. This targeted action is intended to counteract the diminished CTGF levels observed in aging skin, leading to improved collagen density.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
While 'sh-Polypeptide-93' has been generally noted as effective for anti-aging, METHIONYL SH-POLYPEPTIDE-93 specifically lacks a dedicated safety assessment from regulatory bodies such as CIR, SCCS, or FDA. Therefore, its full safety profile remains to be definitively established.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting a promising mechanism for collagen stimulation and anti-aging benefits, the absence of specific regulatory safety reviews and detailed clinical study data for METHIONYL SH-POLYPEPTIDE-93 warrants a 'insufficient-data' rating.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources